Related Experiment Video
Updated: Oct 7, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
Three cases of difficulty in achieving definitive loss of consciousness with remimazolam
Mao Miyanishi1, Toru Yaguramaki2, Yasuhiro Maehara3
1Department of Anesthesiology, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. maooooon527@gmail.com.
Background:
Remimazolam is a novel, ultra-short-acting benzodiazepine used for general anesthesia. Because remimazolam is an emerging drug, the tolerance to remimazolam in benzodiazepine-taking patients has been unclear. Also, the efficacy of remimazolam in different races is not fully elucidated so far.
Case Presentation:
Here we experienced three cases in which high dose of remimazolam was needed for attempting to achieve appropriate anesthetic depth. Two of the three cases were of preoperatively benzodiazepine-taking patients. The other was a case of a Chinese patient. In all three cases, conversion to general anesthesia with propofol was necessitated.
Conclusions:
When signs of inadequate sedative effect of remimazolam are observed in patients of benzodiazepine users or of different races, conversion to another sedative agent such as propofol should be considered.
Insights
High doses of remimazolam may be needed in patients with prior benzodiazepine use or of different races. Conversion to propofol may be necessary if remimazolam (an ultra-short-acting anesthetic) shows inadequate sedation.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Remimazolam is a novel ultra-short-acting benzodiazepine for general anesthesia.
- Its tolerance in patients with prior benzodiazepine use is not well-established.
- Efficacy across different races requires further elucidation.
Purpose of the Study:
- To investigate the anesthetic depth and tolerance of remimazolam in specific patient populations.
- To determine the need for alternative anesthetic agents in challenging cases.
Main Methods:
- Case series of three patients requiring high-dose remimazolam.
- Inclusion of patients with pre-existing benzodiazepine use and of different racial backgrounds.
- Monitoring for anesthetic depth and need for conversion to other agents.
Main Results:
- Two cases involved patients with prior benzodiazepine use.
- One case involved a Chinese patient.
- All three cases necessitated conversion to propofol for adequate anesthesia.
Conclusions:
- Remimazolam may require higher doses in benzodiazepine-tolerant patients or those of different races.
- Conversion to propofol is a viable option when remimazolam shows insufficient sedative effects in these groups.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Stages of General Anesthesia
Management of Insomnia